Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Compound kushen injection relieves tumor-associated macrophage-mediated immunosuppression through TNFR1 and sensitizes hepatocellular carcinoma to sorafenib.

Yang Y, Sun M, Yao W, Wang F, Li X, Wang W, Li J, Gao Z, Qiu L, You R, Yang C, Ba Q, Wang H.

J Immunother Cancer. 2020 Mar;8(1). pii: e000317. doi: 10.1136/jitc-2019-000317.

2.

A New Reliability Analysis Model of the Chegongzhuang Heat-Supplying Tunnel Structure Considering the Coupling of Pipeline Thrust and Thermal Effect.

Zhang J, He S, Wang D, Liu Y, Yao W, Liu X.

Materials (Basel). 2018 Feb 3;11(2). pii: E236. doi: 10.3390/ma11020236.

3.

A Natural CCR2 Antagonist Relieves Tumor-associated Macrophage-mediated Immunosuppression to Produce a Therapeutic Effect for Liver Cancer.

Yao W, Ba Q, Li X, Li H, Zhang S, Yuan Y, Wang F, Duan X, Li J, Zhang W, Wang H.

EBioMedicine. 2017 Aug;22:58-67. doi: 10.1016/j.ebiom.2017.07.014. Epub 2017 Jul 18.

4.

Targeting of tumour-infiltrating macrophages via CCL2/CCR2 signalling as a therapeutic strategy against hepatocellular carcinoma.

Li X, Yao W, Yuan Y, Chen P, Li B, Li J, Chu R, Song H, Xie D, Jiang X, Wang H.

Gut. 2017 Jan;66(1):157-167. doi: 10.1136/gutjnl-2015-310514. Epub 2015 Oct 9.

PMID:
26452628
5.

Japonicone A suppresses growth of Burkitt lymphoma cells through its effect on NF-κB.

Li X, Yang X, Liu Y, Gong N, Yao W, Chen P, Qin J, Jin H, Li J, Chu R, Shan L, Zhang R, Zhang W, Wang H.

Clin Cancer Res. 2013 Jun 1;19(11):2917-28. doi: 10.1158/1078-0432.CCR-12-3258. Epub 2013 Apr 25.

Supplemental Content

Loading ...
Support Center